CoChat
Sign Up
Cited by 10Schizophrenia research and treatmentObesity, Physical Activity, DietEating Disorders and Behaviors

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Obesity in Schizophrenia

Open access
Seeman, Mary V.·2016·Journal of Obesity Management
DOI 10.14302/issn.2574-450x.jom-16-1039
Open this paper in CoChat — free accountOpen PDF

Abstract

Over the last three decades, an epidemic of obesity has markedly affected patients suffering from mental illnesses such as schizophrenia.Antipsychotic medications used to treat schizophrenia are considered as major culprits.The aim of this review is to first consider risk factors, to then outline negative sequelae of obesity for this population, and finally to address timing and content of recommended clinical interventions.Medical databases were searched with the terms ""weight," "obesity," and "schizophrenia."Selection of articles was guided by date of publication; recent papers are preferentially cited.The main findings were that, in addition to antipsychotic medications, socio-economics, lifestyle, immune factors, and circadian rhythms also contribute to obesity risk.A barrier to effective health promotion within psychiatry has been the concern that fears about gaining weight might stop individuals with schizophrenia from taking needed antipsychotic medication.Recommendations, therefore, are to keep the dose of antipsychotic medication as low as possible, avoid polypharmacy, encourage healthy eating and physical activity, address sleep problems and substance use, monitor weight, blood pressure, and metabolic parameters regularly, utilize motivational interviewing techniques and peer support, pay special attention to special needs such as those of women during pregnancy, and include bariatric surgery as a potential intervention.Conclusion: Besides careful attention to medication regimens, the literature supports the active encouragement and support of patient self-management strategies to both prevent and manage obesity in schizophrenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14302/issn.2574-450x.jom-16-1039

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 8 references

Research works printed but not linked: 95

  1. 2. Zammit S Rasmussen F Farahmand B Gunnell D Lewis G Height and body mass index in young adulthood and risk of schizophrenia: a longitudinal study of 1 347 520 Swedish men 2007 Acta Psychiatr. Scand 116 378 385 10.1111/j.1600-0447.2007.01063.x · DOI
  2. 3. D B Allison J W Newcomer A L Dunn J A Blumenthal A N Fabricatore Obesity among those with mental disorders: a National Institute of Mental Health meeting report 2009 Am. J. Prev. Med 36 341 350 10.1016/j.amepre.2008.11.020 · DOI
  3. 4. T A Ban Fifty years chlorpromazine: a historical perspective 2007 Neuropsychiatr. Dis. Treat 3 495 500 · DOI · Paper page
  4. 5. H A Nasrallah Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles 2008 Mol. Psychiatry 13 27 35 · DOI
  5. 6. Coodin S Body mass index in persons with schizophrenia 2001 Can. J. Psychiatry 46 549 555 10.1177/070674370104600610 · DOI
  6. 7. Faulkner G Cohn T Remington G Irving H Body mass index, waist circumference and quality of life in individuals with schizophrenia 2007 Schizophr. Res 90 174 178 10.1016/j.schres.2006.10.009 · DOI
  7. 9. Stubbs B Williams J F P Gaughran Craig T K J How sedentary are people with psychosis? A systematic review and meta-analysis. doi: 10.1016/j.schres.2016.01.034 2016 Schizophr. Res 10.1016/j.schres.2016.01.034 · DOI · Paper page
  8. 10. NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants 2016 Lancet 387 1377 1396 · DOI · Paper page
  9. 12. E J Costello S N Compton Keeler G Angold A Relationships between poverty and psychopathology: A natural experiment 2003 J.A.M.A 290 2023 2029 10.1001/jama.290.15.2023 · DOI · Paper page
  10. 13. Roux Diez V A Mair C Neighborhoods and health 2010 Ann. N.Y. Acad. Sci 1186 125 145 · DOI
  11. 14. Vancampfort D M De Hert A De Hert K V Bosch Soundy A Associations between physical activity and the built environment in patients with schizophrenia: a multi-centre study 2013 Gen. Hosp. Psychiatry 35 653 658 10.1016/j.genhosppsych.2013.07.004 · DOI
  12. 15. Brown S Birtwistle J Roe L Thompson C The unhealthy lifestyle of people with schizophrenia 1999 Psychol. Med 29 697 701 10.1017/s0033291798008186 · DOI
  13. 16. C A Janney Ganguli R C R Richardson R G Holleman Tang G Sedentary behavior and psychiatric symptoms in overweight and obese adults with schizophrenia and schizoaffective disorders 2013 (WAIST Study). Schizophr. Res 145 63 68 · DOI
  14. 17. C A Janney Ganguli R Tang G J A Cauley R G Holleman Physical activity and sedentary behavior measured objectively and subjectively in overweight and obese adults with schizophrenia or schizoaffective disorders 2015 J. Clin. Psychiatry 76 1277 1284 10.4088/jcp.14m09330 · DOI
  15. 18. V A Chouinard S M Pingali Chouinard G D C Henderson S G Mallya Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders. Psychiatry Res 2016 237 304 310 10.1016/j.psychres.2016.01.024 · DOI
  16. 19. L B Palmese J C Ratliff E L Reutenauer K M Tonizzo C M Grilo Prevalence of night eating in obese individuals with schizophrenia and schizoaffective disorder 2013 Compre. Psychiatry 54 276 281 10.1016/j.comppsych.2012.07.014 · DOI
  17. 20. Fritz-Wieacker A Matschinger H Heider D Schindler J Riedel-Heller S Health habits of patients with schizophrenia 2007 Soc. Psychiatry Psychiatr. Epidemiol 42 268 276 · DOI
  18. 21. Paton C Esop R Young C Taylor D Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs 2004 Acta Psychiatr. Scand 110 299 305 10.1111/j.1600-0447.2004.00372.x · DOI
  19. 22. Pistelli F Aquilini F Carrozzi L Weight gain after smoking cessation. Monaldi Arch. Chest Dis 2016 71 81 87 10.4081/monaldi.2009.367 · DOI
  20. 23. Dipasquale S C M Pariante Dazzan P Aguglia E McGuire P The dietary pattern of patients with schizophrenia: a systematic review 2013 J Psychiatr Res 47 197 207 10.1016/j.jpsychires.2012.10.005 · DOI
  21. 24. D C Henderson C P Borba T B Daley Boxill R Nguyen D D Dietary intake profile of patients with schizophrenia 2006 Ann. Clin. Psychiatry 18 99 105 10.1080/10401230600614538 · DOI
  22. 25. Tsuruga K Sugawara N Sato Y Saito M Furukori H Dietary patterns and schizophrenia: a comparison with healthy controls 2015 Neuropsychiatr. Dis. Treat 11 1115 1120 10.2147/ndt.s74760 · DOI
  23. 26. Gough S C L M C O’Donovan Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J.Psychopharmacol;19(6Suppl): 2005 47 55 10.1177/0269881105058380 · DOI
  24. 28. Giaroli G Bass N Strydom A Rantell K McQuillin A Does rare matter? Copy number variants at 16p11.2 and the risk of psychosis: a systematic review of literature and meta-analysis 2014 Schizophr. Res 159 340 346 10.1016/j.schres.2014.09.025 · DOI
  25. 29. D’Angelo D Lebon S Chen Q Martin-Brevet S Green Snyder L Defining the effect of the 16p11.2 duplication on cognition, behavior, and medical comorbidities 2016 J.A.M.A. Psychiatry; 73 20 30 10.1001/jamapsychiatry.2015.2123 · DOI · Paper page
  26. 30. Ryu S I S Huh E Y Cho Cho Y Park T Association study of 60 candidate genes with antipsychotic-induced weight gain in schizophrenia patients 2016 Pharmacopsychiatry 49 51 56 10.1055/s-0035-1569267 · DOI
  27. 31. Padmavati R R G McCreadie Tirupati S Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia 2010 Schizophr. Res 121 199 202 10.1016/j.schres.2010.05.010 · DOI
  28. 33. Correll C U Lencz T A K Malhotra Antipsychotic drugs and obesity. Trends Mol 2011 Med 17 97 107 10.1016/j.molmed.2010.10.010 · DOI
  29. 34. M De Hert Yu W Detraux J Sweers K R van Winkel Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder 2012 C.N.S. Drugs 26 733 759 · DOI
  30. 35. Leucht S Corves C Arbter D Engel R R Li C Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis 2009 Lancet 373 31 41 10.1016/s0140-6736(08)61764-x · DOI · Paper page
  31. 36. Parsons B D B Allison Loebel A Williams K Giller E Weight effects associated with antipsychotics: a comprehensive database analysis 2009 Schizophr. Res 110 103 110 10.1016/j.schres.2008.09.025 · DOI
  32. 38. Froy O Metabolism and circadian rhythms—implications for obesity 2010 Endoc. Rev 31 1 24 · DOI · Paper page
  33. 40. Jagannath A S N Peirson R G Foster Sleep and circadian rhythm disruption in neuropsychiatric illness 2013 Curr. Opin. Neurobiol 23 888 894 10.1016/j.conb.2013.03.008 · DOI
  34. 42. Pritchett D Wulff K P L Oliver D M Bannerman K E Davies Evaluating the links between schizophrenia and sleep and circadian rhythm disruption 2012 J. Neural Transmiss 119 1061 1075 10.1007/s00702-012-0817-8 · DOI
  35. 44. M F Gregor G S Hotamisligil Inflammatory mechanisms in obesity 2011 Ann. Rev. Immunol 29 415 445 10.1146/annurev-immunol-031210-101322 · DOI · Paper page
  36. 45. Steiner J H G Bernstein Schiltz K Müller U J Westphal S Immune system and glucose metabolism interaction in schizophrenia: a chicken–egg dilemma 2014 Prog. Neuro-Psychopharmacol. Biol. Psychiatry 48 287 294 10.1016/j.pnpbp.2012.09.016 · DOI
  37. 46. Shi J D F Levinson Duan J A R Sanders Zheng Y Common variants on chromosome 6p22.1 are associated with schizophrenia 2009 Nature 460 753 757 10.1038/nature08192 · DOI
  38. 47. Stefansson H Ophoff R Steinberg S Andreassen O Cichon S Common variants conferring risk of schizophrenia 2009 Nature 460 744 747 · DOI · Paper page
  39. 48. Varbo A Benn M Davey Smith G Timpson N J Tybjaerg-Hansen A Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease 2015 Circ. Res 116 665 673 10.1161/circresaha.116.304846 · DOI
  40. 49. Ryan M C M Collins P J H Thakore Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia 2003 Am. J. Psychiatry 160 284 289 10.1176/appi.ajp.160.2.284 · DOI
  41. 50. Malan-Müller S Kilian S van den Heuvel L L Bardien S Asmal L A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia 2016 Schizophr. Res 170 1 7 10.1016/j.schres.2015.11.011 · DOI
  42. 51. J P McEvoy J M Meyer D C Goff H A Nasrallah S M Davis Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III 2005 Schizophr. Res; 80 19 32 10.1016/j.schres.2005.07.014 · DOI
  43. 52. L E Rojo P A Gaspar Silva H Risco L Arena P Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness 2013 Psychosom 54 67 73 · DOI
  44. 53. P A Ringen Engh J A B Birkenaes Dieset I O A Andreassen Increased mortality in schizophrenia due to cardiovascular disease-a non-systematic review of epidemiology, possible causes and interventions 2014 Front. Psychiatry 5 137 10.3389/fpsyt.2014.00137 · DOI
  45. 54. Myles H Myles N N A Antic Adams R Chandratilleke M Obstructive sleep apnea and schizophrenia: A systematic review to inform clinical practice 2016 Schizophr. Res 170 222 225 10.1016/j.schres.2015.11.014 · DOI
  46. 55. J W Winkelman Schizophrenia, obesity, and obstructive sleep apnea 2001 J. Clin. Psychiatry 62 8 11 10.4088/jcp.v62n0103 · DOI · Paper page
  47. 56. HsuehWDengTObesity,inflammation, cancer. Ann Rev Pathol. Mechanisms Dis2016 in press;11(1) · DOI
  48. 57. Manu P Khan S Radhakrishnan R M J Russ J M Kane Body mass index identified as an independent predictor of psychiatric readmission 2014 J. Clin. Psychiatry 75 573 577 10.4088/jcp.13m08795 · DOI
  49. 58. Guo X Zhang Z Wei Q Lv H Wu R The relationship between obesity and neurocognitive function in Chinese patients with schizophrenia 2013 BMC Psychiatry 13 109 10.1186/1471-244x-13-109 · DOI
  50. 59. Rashid N A A Lim J Lam M S A Chong Keefe R S E Unraveling the relationship between obesity, schizophrenia and cognition 2013 Schizophr. Res 151 107 112 · DOI
  51. 60. R L Kolotkin P K Corey‐Lisle R D Crosby J M Swanson A V Tuomari Impact of obesity on health‐related quality of life in schizophrenia and bipolar disorder 2008 Obesity 16 749 754 10.1038/oby.2007.133 · DOI
  52. 61. Mizock L The double stigma of obesity and serious mental illnesses: Promoting health and recovery 2012 Psychiatr. Rehab. J 35 466 469 10.1037/h0094581 · DOI
  53. 62. Strassnig M J S Brar Ganguli R Body mass index and quality of life in community-dwelling patients with schizophrenia 2003 Schizophr. Res 62 73 76 10.1016/s0920-9964(02)00441-3 · DOI
  54. 63. Manu P Dima M Shulman D Vancampfort D M De Hert Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management 2015 Acta Psychiatr. Scand 132 97 108 10.1111/acps.12445 · DOI
  55. 64. Jensen M D Ryan D H Apovian C M Ard J D Comuzzie A G 2013AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society 2014 J. Am. Coll. Cardiol 63 2985 3023 · DOI · Paper page
  56. 67. Hjorth P A S Davidsen Kilian R Skrubbeltrang C A systematic review of controlled interventions to reduce overweight and obesity in people with schizophrenia 2014 Acta Psychiatr. Scand 130 279 289 10.1111/acps.12245 · DOI
  57. 68. Shiers D P B Jones Field S Early intervention in psychosis: keeping the body in mind 2009 Br. J. Gen. Pract 59 395 396 10.3399/bjgp09x420888 · DOI
  58. 69. A J Mitchell M De Hert Promotion of physical health in persons with schizophrenia: can we prevent cardiometabolic problems before they begin? Acta Psychiatr 2015 Scand 132 83 85 10.1111/acps.12466 · DOI
  59. 70. L H Beebe Obesity in schizophrenia: screening, monitoring, and health promotion 2008 Perspect. Psychiatr. Care 44 25 31 · DOI
  60. 71. A N Thorndike E D Achtyes Cather C Pratt S G N Pachas Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial 2016 J. Clin. Psychiatry 77 320 326 10.4088/jcp.15m10074 · DOI
  61. 72. S R Marder S M Essock A L Miller R W Buchanan D E Casey Physical health monitoring of patients with schizophrenia 2004 Am. J. Psychiatry 161 1334 1349 10.1176/appi.ajp.161.8.1334 · DOI
  62. 73. S J Bartels S I Pratt K A Aschbrenner L K Barre Jue K Clinically significant improved fitness and weight loss among overweight persons with serious mental illness 2013 Psychiatr. Serv 64 729 736 10.1176/appi.ps.003622012 · DOI
  63. 74. Niv N A N Cohen Hamilton A Reist C A S Young Effectiveness of a psychosocial weight management program for individuals with schizophrenia 2014 J. Behav. Health Serv. Res 41 370 80 · DOI
  64. 75. Firth J Rosenbaum S Stubbs B Vancampfort D Carney R Preferences and motivations for exercise in early psychosis. doi: 10.1111/acps.12562. Acta Psychiatr 2016 Scand 10.1111/acps.12562 · DOI
  65. 76. Soundy A Freeman P Stubbs B Probst M Coffee P The transcending benefits of physical activity for individuals with schizophrenia: a systematic review and meta-ethnography. Psychiatry Res 2014 220 11 19 10.1016/j.psychres.2014.07.083 · DOI
  66. 77. Z D Erickson S J Mena J M Pierre L H Blum Martin E Behavioral interventions for antipsychotic medication–associated obesity: A randomized, controlled clinical trial 2016 J. Clin. Psychiatry 77 183 189 10.4088/jcp.14m09552 · DOI
  67. 78. Gorczynski P Faulkner G Exercise therapy for schizophrenia. Cochrane Database Syst 2010 Rev 12 004412 · DOI
  68. 79. Loh C J M Meyer S G Leckband A comprehensive review of behavioral interventions for weight management in schizophrenia 2006 Ann. Clin. Psychiatry 18 23 31 10.1080/10401230500464646 · DOI
  69. 80. M C Ward D T White B G Druss A meta-review of lifestyle interventions for cardiovascular risk factors in the general medical population: lessons for individuals with serious mental illness 2015 J. Clin. Psychiatry 76 477 486 10.4088/jcp.13r08657 · DOI
  70. 81. Anderson G Maes M Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects 2012 Metab. Brain Dis 27 113 119 10.1007/s11011-012-9307-9 · DOI · Paper page
  71. 82. Modabbernia A Heidari P Soleimani R Sobhani A Z A Roshan Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: Randomized double-blind placebo-controlled study 2014 J. Psychiatr. Res 53 133 140 10.1016/j.jpsychires.2014.02.013 · DOI
  72. 83. Romo‐Nava F Alvarez‐Icaza González D Fresán‐Orellana A Saracco Alvarez R Becerra‐Palars C Melatonin attenuates antipsychotic metabolic effects: an eight‐week randomized, double‐blind, parallel‐group, placebo‐controlled clinical trial 2014 Bipolar Disord 16 410 421 · DOI
  73. 84. D C Henderson Fan X P M Copeland Sharma B C P Borba Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients 2009 J. Clin. Psychopharmacol 29 165 168 10.1097/jcp.0b013e31819a8dbe · DOI
  74. 85. J W Newcomer J A Campos R N Marcus Breder C R M Berman A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffectve disorder switched from olanzapine 2008 J. Clin. Psychiatry 69 1046 1056 10.4088/jcp.v69n0702 · DOI
  75. 86. Mukundan A Faulkner G Cohn T Remington G Anti-psychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems. Cochrane Database Syst 2010 Rev 12 006629 · DOI
  76. 87. Stroup T S McEvoy J P Ring K D Hamer R H LaVange L M A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP) 2011 Am. J. Psychiatry 168 947 956 10.1176/appi.ajp.2011.10111609 · DOI
  77. 88. Maayan L Vakhrusheva J Correll C U Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis 2010 Neuropsychopharmacol 35 1520 1530 10.1038/npp.2010.21 · DOI
  78. 89. Wu R R J P Zhao Jin H Shao P M S Fang Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial 2008 J.A.M.A 299 185 193 10.1001/jama.2007.56-b · DOI · Paper page
  79. 90. Poston L L F Harthoorn E M vanderBeek Obesity in pregnancy: implications for the mother and lifelong health of the child. A consensus statement 2011 Pediatr. Res 69 175 180 10.1203/pdr.0b013e3182055ede · DOI
  80. 91. Tsoi E Shaikh H Robinson S T G Obesity in pregnancy: a major healthcare issue 2010 Postgrad. Med. J 86 617 623 10.1136/pgmj.2010.098186 · DOI
  81. 92. H F Fuchs Laughter V C R Harnsberger R C Broderick Berducci M Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success 2016 Surg. Endosc 30 251 258 · DOI
  82. 93. Hamoui N Kingsbury S G J Anthone P F Crookes Surgical treatment of morbid obesity in schizophrenic patients 2004 Obes. Surg 14 349 352 10.1381/096089204322917873 · DOI
  83. 94. Davidson L Chinman M Kloos B Weingarten R Stayner D Peer support among individuals with severe mental illness: A review of the evidence 1999 Clin. Psychol. Sci. Pract 6 165 187 10.1093/clipsy.6.2.165 · DOI
  84. 95. Lucksted A McNulty K Brayboy L Forbes C Initial evaluation of the Peer-to-Peer program 2015 Psychiatr. Serv 60 250 253 · DOI
  85. 97. Rummel-Kluge C Stiegler-Kotzor M Schwarz C W P Hansen Kissling W Peer-counseling in schizophrenia: patients consult patients. Patient Educ 2008 Couns 70 357 362 10.1016/j.pec.2007.11.001 · DOI
  86. 98. Greene J J H Hibbard Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes 2012 J. Gen. Intern. Med 27 520 526 · DOI
  87. 99. C E Blixen Kanuch A A T Perzynski Thomas C N V Dawson Barriers to self-management of serious mental illness and diabetes 2016 Am. J. Health Behav 40 194 204 10.5993/ajhb.40.2.4 · DOI · Paper page
  88. 100. R W Goldberg Dickerson F Lucksted A C H Brown Weber E Living well: an intervention to improve self-management of medical illness for individuals with serious mental illness 2013 Psychiatr. Serv 64 51 57 10.1176/appi.ps.201200034 · DOI
  89. 101. K A Aschbrenner J A Naslund L E Gill S J Bartels Ben-Zeev D A qualitative study of client-clinician text exchanges in a mobile health intervention for individuals with psychotic disorders and substance use 2016 J. Dual Diagn 12 63 71 10.1080/15504263.2016.1145312 · DOI
  90. 102. L H Beebe R F Harris Using pedometers to document physical activity in patients with schizophrenia spectrum disorders: a feasibility study 2012 J. Psychosoc. Nurs. Ment. Health Serv 50 44 49 · DOI
  91. 103. Ben-Zeev D S M Kaiser C J Brenner Begale M Duffecy J Development and usability testing of FOCUS: A smartphone system for self-management of schizophrenia 2013 Psychiatr. Rehab. J 36 289 296 10.1037/prj0000019 · DOI
  92. 104. Gaebel W Großimlinghaus I Kerst A Cohen Y Hinsche-Böckenholt A European Psychiatric Association (EPA) guidance on the quality of eMental health interventions in the treatment of psychotic disorders 2016 Eur. Arch. Psychiatry Clin. Neurosci 266 125 137 10.1007/s00406-016-0677-6 · DOI
  93. 105. Firth J Cotter J Torous J Bucci S J A Firth Mobile phone ownership and endorsement of “mhealth” among people with psychosis: A meta-analysis of cross-sectional studies 2016 Schizophr. Bull 42 448 455 · DOI · Paper page
  94. 107. Ben-Zeev D C J Brenner Begale M Duffecy J D C Mohr Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia 2014 Schizophr. Bull 40 1244 1253 10.1093/schbul/sbu033 · DOI · Paper page
  95. 109. B J Miller Stewart A Schrimsher J Peeples D P F Buckley How connected are people with schizophrenia? Cell phone, computer, email, and social media use 2015 Psychiatr. Res 225 458 463 10.1016/j.psychres.2014.11.067 · DOI · Paper page

Cited by

Sorted by citations

See all 10

Metadata

Authors
Seeman, M. V.
Affiliations
University of Toronto (CA)
Corresponding author
Seeman, Mary V.
Venue
Journal of Obesity Management
Publisher
Open Access Pub
Published
2016
Volume
1
Issue
1
Pages
10-24
ISSN
2574-450X (ISSN-L)
DOI
10.14302/issn.2574-450x.jom-16-1039
OpenAlex
W2752683757
Cited by
10
References
8
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 1
FWCI
0.51
Type
journal article
Language
en
Open access
Licence
Locations
Journal Of Obesity Management (publishedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
  • Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
Keywords
obesity, schizophrenia, antipsychotic-induced weight gain, obesity risk factors, socioeconomic factors, lifestyle factors, immunological factors, circadian rhythm, antipsychotic dose reduction, polypharmacy, healthy eating, physical activity, sleep disorders, substance use, weight monitoring, metabolic parameters, motivational interviewing, peer support, bariatric surgery, pregnancy, self-management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review